Immatics Nv Stock Today
| IMTX Stock | USD 10.34 0.29 2.73% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Immatics is trading at 10.34 as of the 23rd of May 2024; that is -2.73 percent decrease since the beginning of the trading day. The stock's open price was 10.63. Immatics has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Immatics NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of April 2024 and ending today, the 23rd of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 2nd of July 2020 | Category Healthcare | Classification Health Care |
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. The company has 103.05 M outstanding shares of which 8.89 M shares are currently shorted by private and institutional investors with about 26.92 trading days to cover. More on Immatics NV
Moving together with Immatics Stock
| 0.83 | VRAX | Virax Biolabs Group Fiscal Year End 12th of June 2024 | PairCorr |
| 0.87 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.77 | KPRX | Kiora Pharmaceuticals Earnings Call This Week | PairCorr |
Moving against Immatics Stock
| 0.81 | RZLT | Rezolute Fiscal Year End 12th of September 2024 | PairCorr |
| 0.72 | NTRB | Nutriband Financial Report 14th of June 2024 | PairCorr |
| 0.57 | INDP | Indaptus Therapeutics | PairCorr |
| 0.41 | CRDL | Cardiol Therapeutics | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Immatics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Immatics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Immatics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Immatics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Immatics' managers, analysts, and investors.
Environmental | Governance | Social |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Immatics report their recommendations after researching Immatics' financial statements, talking to executives and customers, or listening in on Immatics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Immatics NV. The Immatics consensus assessment is calculated by taking the average forecast from all of the analysts covering Immatics. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Immatics' liquidity, profitability, solvency, and operating efficiency, Immatics NV is not in a good financial situation at this time. It has a very high odds of going through financial crisis in June. Financial strength of Immatics NV is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immatics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Immatics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Immatics' financial leverage. It provides some insight into what part of Immatics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immatics NV (IMTX) is traded on NASDAQ Exchange in USA. It is located in Paul-Ehrlich-Strasse 15, Tübingen, Germany, 72076 and employs 432 people. Immatics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Immatics's market, we take the total number of its shares issued and multiply it by Immatics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Immatics NV conducts business under Biotechnology sector and is part of Health Care industry. The entity has 103.05 M outstanding shares of which 8.89 M shares are currently shorted by private and institutional investors with about 26.92 trading days to cover.
Immatics NV currently holds about 324.38 M in cash with 18.23 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.0.
Check Immatics Probability Of Bankruptcy
Ownership AllocationImmatics secures a total of 103.05 Million outstanding shares. The majority of Immatics NV outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Immatics to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Immatics NV. Please pay attention to any change in the institutional holdings of Immatics NV as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Immatics Ownership Details
Immatics Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Immatics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Immatics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immatics' value.| Instituion | Recorded On | Shares | |
| Rock Springs Capital Management Lp | 2023-12-31 | 1.9 M | |
| Orbimed Advisors, Llc | 2023-12-31 | 1.5 M | |
| Rtw Investments, Llc | 2023-12-31 | 1.5 M | |
| 683 Capital Management Llc | 2023-12-31 | 1.1 M | |
| Stempoint Capital Lp | 2023-12-31 | 1 M | |
| Hhg Plc | 2023-12-31 | 704.4 K | |
| University Of Texas Investment Mgmt Co | 2023-12-31 | 697.4 K | |
| Artisan Partners Limited Partnership | 2023-12-31 | 689 K | |
| Adage Capital Partners Gp Llc | 2023-12-31 | 621.5 K | |
| Wellington Management Company Llp | 2023-12-31 | 6.4 M | |
| Baker Bros Advisors Lp | 2023-12-31 | 5.8 M |
Immatics Historical Income Statement
Immatics NV Income Statement is one of the three primary financial statements used for reporting Immatics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Immatics NV revenue and expense. Immatics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Immatics' Net Interest Income is fairly stable compared to the past year. Interest Income is likely to rise to about 14.5 M in 2024, whereas Interest Expense is likely to drop slightly above 789.5 K in 2024. View More FundamentalsImmatics Stock Against Markets
Picking the right benchmark for Immatics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Immatics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Immatics is critical whether you are bullish or bearish towards Immatics NV at a given time. Please also check how Immatics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Immatics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Immatics Corporate Management
Elected by the shareholders, the Immatics' board of directors comprises two types of representatives: Immatics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Immatics. The board's role is to monitor Immatics' management team and ensure that shareholders' interests are well served. Immatics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Immatics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrea Mokler | VP Sciences | Profile | |
| Miriam Meyer | VP Affairs | Profile | |
| PHR MBA | Director HR | Profile | |
| Edward Sturchio | G Sec | Profile | |
| Arnd MBA | Chief Officer | Profile | |
| Toni Weinschenk | CoFounder Officer | Profile |
How to buy Immatics Stock?
Before investing in Immatics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Immatics. To buy Immatics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Immatics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Immatics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Immatics NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Immatics NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Immatics NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Immatics Stock please use our How to Invest in Immatics guide.
Already Invested in Immatics NV?
The danger of trading Immatics NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Immatics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Immatics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Immatics NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Immatics NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immatics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immatics Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immatics Nv Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Immatics Stock analysis
When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.30) | Revenue Per Share 0.67 | Quarterly Revenue Growth (0.58) | Return On Assets (0.14) | Return On Equity (0.44) |
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.